B(C6F5)3-Catalyzed Asymmetric Reductive Amination of Ketones with Ammonia Borane

Incorporation of Chiral Frustrated Lewis Pair into Metal-Organic Framework with Tailored Microenvironment for Heterogeneous Enantio- and Chemoselective Hydrogenation

The development of efficient heterogeneous catalysts with multiselectivity (e.g., enantio- and chemoselectivity) has long been sought after but with limited progress being made so far. To achieve enantio- and chemoselectivity in a heterogeneous system, as inspired by enzymes, we illustrate herein an approach of creating an enzyme-mimic region (EMR) within the nanospace of a metal-organic framework (MOF) as exemplified in the context of incorporating a chiral frustrated Lewis pair (CFLP) into a MOF with a tailored pore environment. Due to the high density of the EMR featuring the active site of CFLP and auxiliary sites of the hydroxyl group/open metal site within the vicinity of CFLP, the resultant EMR@MOF demonstrated excellent catalysis performance in heterogeneous hydrogenation of α,β-unsaturated imines to afford chiral β-unsaturated amines with high yields and high enantio- and chemoselectivity. The role of the hydroxyl group/open metal site in regulating chemoselectivity was proved by the observation of a catalyst-substrate interaction experimentally, which was also rationalized by computational results. This work not only contributes a MOF as a new platform for multiselective catalysis but also opens a promising avenue to develop heterogeneous catalysts with multiselectivity for challenging yet important transformations.

Improved Process for the Synthesis of 3-(3-Trifluoromethylphenyl)propanal for More Sustainable Production of Cinacalcet HCl

Cinacalcet (I), sold as hydrochloride salt, is a calcimimetic drug which has been approved for the treatment of secondary hyperparathyroidism in patients with chronic renal disease and for the treatment of hypercalcemia in patients with parathyroid carcinoma. Here, an improved method for the synthesis of 3-(3-trifluoromethylphenyl)propanal (II), a key intermediate for the preparation of I, is described. The protocol required a Mizoroki-Heck cross-coupling reaction between 1-bromo-3-(trifluoromethyl)benzene and acroleine diethyl acetal, catalyzed by Pd(OAc)2 in the presence of nBu4NOAc (tetrabutylammonium acetate), followed by the hydrogenation reaction of the crude mixture of products in a cascade process. Palladium species, at the end of the reaction, were efficiently recovered as Pd/Al2O3. The procedure was developed under conventional heating conditions as well as under microwave-assisted conditions. The obtained mixture of 1-(3,3-diethoxypropyl)-3-(trifluoromethyl)benzene (III), impure for ethyl 3-(3-trifluoromethylphenyl) propanoate (IV), was finally treated, under mild conditions, with potassium diisobutyl-tert-butoxyaluminum hydride (PDBBA) to obtain after hydrolysis 3-(3-trifluoromethylphenyl)propanal (II), in an excellent overall yield and very high purity. Microwave conditions permitted a reduction in reaction times without affecting selectivity and yield. The final API was obtained through reductive amination of (II) with (R)-(+)-1-(1-naphthyl)ethylamine (V) using a catalyst prepared by us with a very low content of precious metal.

Nms-Amides: An Amine Protecting Group with Unique Stability and Selectivity

p-Toluenesulfonyl (Tosyl) and nitrobenzenesulfonyl (Nosyl) are two of the most common sulfonyl protecting groups for amines in contemporary organic synthesis. While p-toluenesulfonamides are known for their high stability/robustness, their use in multistep synthesis is plagued by difficult removal. Nitrobenzenesulfonamides, on the other hand, are easily cleaved but display limited stability to various reaction conditions. In an effort to resolve this predicament, we herein present a new sulfonamide protecting group, which we term Nms. Initially developed through in silico studies, Nms-amides overcome these previous limitations and leave no room for compromise. We have investigated the incorporation, robustness and cleavability of this group and found it to be superior to traditional sulfonamide protecting groups in a broad range of case studies.

Asymmetric Transfer Hydrogenative Amination of Benzylic Ketones Catalyzed by Cp*Ir(III) Complexes Bearing a Chiral N-(2-Picolyl)sulfonamidato Ligand

A convenient asymmetric reductive amination of benzylic ketones (α-arylated ketones) catalyzed by newly designed Cp*Ir complexes bearing a chiral N-(2-picolyl)sulfonamidato ligand was developed. Using readily available β-amino alcohols as chiral aminating agents, a range of benzo-fused and acyclic ketones were successfully reduced with formic acid in methanol at 40 °C to afford amines with favorable chemo- and diastereoselectivities. The amino alcohol-derived chiral auxiliary was easily removed by mild periodic oxidants, leading to optically active primary β-arylamines without erosion of the optical purity (up to 97% ee). The excellent catalytic performance was retained even upon lowering the amount of catalyst to a substrate/catalyst (S/C) ratio of 20,000, and the amination could be performed on a large scale exceeding 100 g. The precise hydride transfer to iminium species generated from the ketonic substrate and the chiral amine counterpart was suggested by the mechanistic studies on stoichiometric reactions of isolable hydridoiridium complexes and model intermediates such as N,O-acetal, enamine, and iminium compounds.

A Theoretical Study on the Borane-Catalyzed Reductive Amination of Aniline and Benzaldehyde with Dihydrogen: The Origins of Chemoselectivity

Density functional theory calculations are used in this study to investigate the product selectivity and mechanism of borane-catalyzed reductive aldehyde amination by a H₂ reducing agent. Knowing that different boranes yield different products, two typical boranes, (B(2,6-Cl₂C₆H₃)(p-HC₆F₄)₂ and B(C₆F₅)₃), are studied. Of the seven possible pathways of B(2,6-Cl₂C₆H₃)(p-HC₆F₄)₂-catalyzed aldehyde amination analyzed herein, four are favorable. Three of the four favorable pathways involve imine intermediates, and the fourth is a Lewis acid-base synergistic pathway that involves amine-alcohol condensation. As for the B(C₆F₅)₃ catalyst, it forms a highly stable Lewis adduct with aniline, which impedes the hydrogenation of imine. Therefore, the product of B(C₆F₅)₃-catalyzed reductive amination of benzaldehyde and aniline is an imine. The linear relationship between the charge on the boron atom in the Lewis acid and the relative energies of the Lewis adduct and H₂ splitting transition state indicates that this parameter determines product selectivity. Indeed, when the natural charge on boron is larger than 1, an amine is produced, whereas when the charge is less than 1, an imine is produced. Hence, the selectivity of products can be controlled by adjusting the natural charge of the boron atom in the Lewis acid catalyst.

Reductive amination of ketones/aldehydes with amines using BH3N(C2H5)3 as a reductant

Herein, we report the first example of efficient reductive amination of ketones/aldehydes with amines using BH₃N(C₂H₅)₃ as a catalyst and a reductant under mild conditions, affording various tertiary and secondary amines in excellent yields. A mechanistic study indicates that BH₃N(C₂H₅)₃ plays a dual function role of promoting imine and iminium formation and serving as a reductant in reductive amination.

Amine-Boranes as Transfer Hydrogenation and Hydrogenation Reagents: A Mechanistic Perspective

Transfer hydrogenation (TH) has historically been dominated by Meerwein-Ponndorf-Verley (MPV) reactions. However, with growing interest in amine-boranes, not least ammonia-borane (H3 N⋅BH3 ), as potential hydrogen storage materials, these compounds have also started to emerge as an alternative reagent in TH reactions. In this Review we discuss TH chemistry using H3 N⋅BH3 and their analogues (amine-boranes and metal amidoboranes) as sacrificial hydrogen donors. Three distinct pathways were considered: 1) classical TH, 2) nonclassical TH, and 3) hydrogenation. Simple experimental mechanistic probes can be employed to distinguish which pathway is operating and computational analysis can corroborate or discount mechanisms. We find that the pathway in operation can be perturbed by changing the temperature, solvent, amine-borane, or even the substrate used in the system, and subsequently assignment of the mechanism can become nontrivial.

Tris(pentafluorophenyl)borane catalyzed C-C and C-heteroatom bond formation

A series of boron based Lewis acids have been reported to date, but among them, tris(pentafluorophenyl)borane (BCF) has gained the most significant attention in the synthetic chemistry community. The viability of BCF as a potential Lewis acid catalyst has been vastly explored in organic and materials chemistry due to its thermal stability and commercial availability. Most explorations of BCF chemistry in organic synthesis has occurred in the last two decades and many new catalytic reactivities are currently under investigation. This review mainly focuses on recent reports from 2018 onwards and provides a concise knowledge to the readers about the role of BCF in metal-free catalysis. The review has mainly been categorized by different types of organic transformation mediated through BCF catalysis for the C-C and C-heteroatom bond formation.

Iridium-catalyzed asymmetric hydrogenation of N-phosphinoylimine

On catalysis with an iridium tridentate catalyst, prochiral N-phosphinoylimines were hydrogenated with high enantioselectivity and reactivity. An outer-sphere reaction model was proposed in this hydrogenation of CN bonds.

Ammonia borane as a reducing agent in organic synthesis

Ammonia borane is gaining increasing attention as a sustainable and atom-economical winning reagent for the reduction of several substrates.

Reductive Amination in the Synthesis of Pharmaceuticals

Reductive amination plays a paramount role in pharmaceutical and medicinal chemistry owing to its synthetic merits and the ubiquitous presence of amines among biologically active compounds. It is one of the key approaches to C-N bond construction due to its operational easiness and a wide toolbox of protocols. Recent studies show that at least a quarter of C-N bond-forming reactions in the pharmaceutical industry are performed via reductive amination. This Review concisely compiles information on 71 medical substances that are synthesized by reductive amination. Compounds are grouped according to the principle of action, which includes drugs affecting the central nervous system, drugs affecting the cardiovascular system, anticancer drugs, antibiotics, antiviral and antifungal medicines, drugs affecting the urinary system, drugs affecting the respiratory system, antidiabetic medications, drugs affecting the gastrointestinal tract, and drugs regulating metabolic processes. A general synthetic scheme is provided for each compound, and the description is focused on reductive amination steps. The green chemistry metric of reaction mass efficiency was calculated for all reactions.

Enantioselective synthesis of (R)-Cinacalcet via cobalt-catalysed asymmetric Negishi cross-coupling

A novel enantioselective synthesis of (R)-cinacalcet with 99% enantiomeric excesses (ee) has been achieved. The main strategies of the approach include a gram-scale cobalt-catalysed asymmetric cross-coupling of racemic ester with arylzinc reagent, Hoffman-type rearrangement of acidamide, the amidation of chiral amine, and improving the ee of chiral amide from 87% to 99% via recrystallization.